author-photo

Nora Vago-Ady

3

Papers

13

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

BEVATEM: Phase II study of bevacizumab (B) in combination with temozolomide (T) in patients (pts) with first-line metastatic uveal melanoma (MUM): Final results.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
HIT: A multicenter phase I-II study of trastuzumab administered by intrathecal injection for leptomeningeal meningitis of HER2+ metastatic breast cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BEVATEM: Phase II single-center study of bevacizumab in combination with temozolomide in patients (pts) with first-line metastatic uveal melanoma (MUM): First-step results.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)